HealthTech Integrates 2023 Track 1


HealthTech is an integral part of today’s healthcare, how do we ensure delivery of the benefits it offers?

Welcome and opening remarks

NEIL MESHER | Senior Vice President |  Philips, Western Europe

Fireside Chat

Fireside Chat 1

Steven Roberts | Chief Scientific Advisor | Barclays UK

Interviewed by

Jane Kennedy | Chief Business Officer | Discovery Park

Fireside Chat 2

Cristina Duran | Chief Digital Health Officer, R&D | AstraZeneca

Interviewed by

Paul Wicks | Independent Consultant | Wicks Digital Health

Lighting the way

With the advent of RWD, omics data, imaging data, Dx data etc, enabling prediction of disease progression following early diagnosis – can we begin to practice preventative medicine now rather than symptom treatment as we have been?


Louise Jopling | Commercial Director | Eastern Academic Health Science Network


Debora Lucarelli | Chief Executive Officer | Enhanc3D Genomics

Anthony Finbow | Chief Executive Officer | Eagle Genomics

Jane Theaker | Chief Executive Officer | PBD Biotech

Ellie Halliday | Data Privacy & Compliance Manager | Talking Medicines

Cleaner future?

How does this industry embrace sustainability? Are we going to be able to move away from single-use plastics and enable recycling? Have we got the answer to the carbon costs of data processing and storage etc?


Martin Baxter | Chief Executive Officer | IEMA


Addie MacGregor | Sustainability Executive | ABHI

Michelle Sullivan | Head Of Public Affairs | Boston Scientific

Daniel Coole | Managing Director | Surgical Holdings

Brennan Miles | Head of Drug Delivery | Team Consulting

Pete Waddingham | National NetZero Lead | The AHSN Network

Wear’s my data?

What actionable value can be achieved from wearables data? With multiple owners of these data in multiple formats – how can we join the dots on an individual patient level and enable better informed clinical decision making?


Beverley Vaughan | Innovation Hubs Director | ARISE


Emilė Radytė | Co-founder & CEO | Samphire Neuroscience

Camille Carroll | Honorary Consultant Neurologist | Plymouth Hospitals NHS Trust

Nigel Brokenshire | Head of Digital Healthcare UK/I | Bayer PLC

Rahul Kapoor | Director of Health Tech | CPI

Luca Lipani | Co-Founder & Chief Executive Officer | Transdermal Diagnostics

Navigating the regulatory pathway

How do you prepare your regulatory strategy to enable a rapid route to market? US, EU, UK – selecting the right regulatory pathway?



Hugh Harvey | Managing Director | Hardian Health


Vishal Thakker | Head of UK Approved Body & Senior Regulatory Lead | British Standards Institution (BSI)

Ema Kufel | Co-founder & UK Chief Executive Officer | Prosoma

Mina Frost | Founder & Director | Decode X

James Fry | Partner and Head of Life Sciences | Mills & Reeve

Ama Frimpong | Head of Product Development | 52 North Health

The brightest and the best

The need for Covid-19 testing saw an explosion in the molecular diagnostics arena and rapid adoption – How do we build on that success? (PCR and beyond – facilitating early infectious disease detection)


Pari Datta | Principle Consultant – Strategy/Diagnostics & Life Sciences | Cambridge Design Partnership


John Tyson | Head of the North East Innovation Lab | Newcastle Upon Tyne Hospitals NHS Foundation Trust

Frederick Manduca | Director | Newfoundland Diagnostics

Jonathan O’Halloran | Chief Executive Officer | QuantuMDx Group

Peter Whawell | Chief Executive Officer | Proxximos

Robert Porter | Chief Executive Officer | RAPIvD